Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.700
+0.050 (1.89%)
At close: Feb 11, 2026, 4:00 PM EST
2.680
-0.020 (-0.74%)
After-hours: Feb 11, 2026, 4:10 PM EST
CNTB Market Cap
CNTB has a market cap or net worth of $150.94 million as of February 11, 2026.
Market Cap
150.94M
Enterprise Value
91.91M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since the IPO on September 3, 2025, CNTB's market cap has increased from $110.89M to $150.94M, an increase of 36.12%. That is a compound annual growth rate of 102.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 148.14M | -6.03% |
| Dec 31, 2025 | 157.65M | 42.17% |
| Sep 3, 2025 | 110.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 156.35M |
| ProQR Therapeutics | 155.91M |
| Zentalis Pharmaceuticals | 155.40M |
| Elicio Therapeutics | 152.03M |
| Acumen Pharmaceuticals | 149.62M |
| Corbus Pharmaceuticals Holdings | 146.75M |
| Caribou Biosciences | 146.74M |
| Sangamo Therapeutics | 144.96M |